Angiotensinogen: Molecular biology, biochemistry and physiology

International Journal of Biochemistry and Cell Biology

Volumn 28, Issue 11, 1996, Pages 1211-1222

  Morgan, L ^a   Pipkin, F Broughton ^a   Kalsheker, N ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Angiotensinogen; Gene regulation; Hypertension; Renin angiotensin system

Indexed keywords

ANDROSTANOLONE; ANGIOTENSINOGEN; BUCLADESINE; CYCLIC AMP; DEXAMETHASONE; ESTRADIOL; INSULIN; LIOTHYRONINE; MESSENGER RNA; ORAL CONTRACEPTIVE AGENT; STREPTOZOCIN; THYROXINE;

ADRENAL GLAND; ADRENAL INSUFFICIENCY; BRAIN; CUSHING SYNDROME; GENE CONTROL; GENETIC ANALYSIS; HUMAN; HYPERTENSION; KIDNEY; LEUKOCYTE; LIVER; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PLACENTA; PREGNANCY; PROMOTER REGION; PROTEIN FAMILY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TRANSGENIC ANIMAL; VASCULAR TISSUE;

ANGIOTENSINOGEN; ANIMALS; BASE SEQUENCE; DNA; FEMALE; GENE EXPRESSION; HUMANS; HYPERTENSION; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; PREGNANCY; RATS; RENIN-ANGIOTENSIN SYSTEM;

EID: 0030293795     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(96)00086-6     Document Type: Review

References (87)

1. Arngrimsson R., Purandare S., Connor M., Walker J., Bjornsson S., Soubrier F., Kotelevstev Y., Geirsson R. and Bjornsson H. (1993) Angiotensinogen: a candidate gene involved in pre-eclampsia? Nat, Genet. 4, 114-115.
2. Bennett C. L., Schrader A. P. and Morris B. J. (1993) Cross-sectional analysis of Met235 to Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem. Biophys. Res. Commun. 197, 833-839.
3. Brilla C. G., Pick R., Tan L. B., Janicki J. S. and Weber K. T. (1990) Remodeling of the rat right and left ventricles in experimental hypertension. Circ. Res. 67, 1355-1364.
4. Campbell D. J. (1987) Circulating and tissue angiotensin systems. J. Clin. Invest. 79, 1-6.
5. Campbell D. J., Bouhnik J., Coezy E., Menard J. and Corvol P. (1985a) Characterization of precursor and secreted forms of human angiotensinogen. J. Clin. Invest. 75, 1880-1893.
6. Campbell D. J., Bouhnik J., Coezy E., Menard J. and Corvol P. (1985b) Processing of rat and human angiotensinogen precursors by microsomal membranes. Mol. Cell Endocrinol. 43, 31-40.
7. Campbell D. J., Kladis A., Skinner S. L. and Whitworth J. A. (1991) Characterization of angiotensin peptides in plasma of anephric man. J. Hypertens. 9, 265-274.
8. Cassis L. A. (1992) Downregulation of the renin-angiotensin system in streptozotocin-diabetic rats. Am. J. Physiol. 262, E105-109.
9. Caulfield M., Lavender P., Farrall M., Munroe P., Lawson M., Turner P. and Clark A. J. L. (1994) Linkage of the angiotensinogen gene to essential hypertension. New Engl. J. Med. 330, 1629-1633.
10. Culman J., Hohle S., Qadri F., Edling O., Blume A., Lebrun C. and Unger T. (1995) Angiotensin as neuromodulator/ neurotransmitter in central control of body fluid and electrolyte homeostasis. Clin. Exp. Hypertens. 17, 281-293.
11. Darby I. A., Congui M., Fernley R. T., Sernia C. and Coghlan J. P. (1994) Cellular and ultrastructural location of angiotensinogen in rat and sheep kidney. Kidney Int. 46, 1557-1560.
12. Deschepper C. F. (1994) Angiotensinogen: hormonal regulation and relative importance in the generation of angiotensin II. Kidney Int. 46, 1561-1563.
13. Doolittle R. F. (1983) Angiotensinogen is related to the antitrypsin-antithrombin-ovalbumin family. Science 222, 417-419.
14. Dzau V. J., Gibbons G. H. and Pratt R. E. (1991) Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension 18, II100-II105.
15. Everett A. D., Chevalier R. L. and Ariel Gomez R. (1991) Hepatic angiotensinogen gene regulation in the fetal and pregnant rat. Pediatr. Res. 30, 252-255.
16. Fasola F., Martz B. L. and Helmer O. M. (1968) Plasma renin activity during supine exercise in offspring of hypertensive parents. J. Appl. Physiol. 25, 410-415.
17. Fukamizu A., Takahashi S., Seo M., Tada M., Tanimoto K., Uehara S. and Murakami K. (1990a) Structure and expression of the human angiotensinogen gene. J. biol. Chem. 265, 7576-7582.
18. Fukamizu A., Takahashi S. and Murakami K. (1990b) Expression of the human angiotensinogen gene in human cell lines. J. Cardiovasc. Pharmacol. 16, Suppl 4, S11-13.
19. Fukamizu A., Sugimura K., Takimoto E., Sugiyama F., Seo M., Takahashi S., Hatae T., Kajiwara N., Yagami K. and Murakami K. (1993) Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J. biol. Chem. 268, 11617-11621.
20. Gaillard I., Clauser E. and Corvol P. (1989) Structure of human angiotensinogen gene. DNA 8, 87-99.
21. Gaillard-Sanchez I., Mattei M. G., Clauser E. and Corvol P. (1990a) Assignment by in situ hybridization of the human angiotensinogen gene to chromosome band 1q4, the same region as the human renin gene. Hum. Genet. 84, 341-343.
22. Gaillard-Sanchez I., Bruneval P., Clauser E., Belair M. F., Da Silva J. L., Bariety J., Camilleri J. P. and Corvol P. (1990b) Successful detection by in situ cDNA hybridisation of three members of the serpin family: angiotensinogen, alpha 1 protease inhibitor, and antithrombin III in human hepatocytes. Mol. Pathol. 3, 216-222.
23. Ganong W. F. (1994) Origin of the angiotensin II secreted by cells. Proc. Soc. Exp. Biol. Med. 205, 213-219.
24. Gelly J. L., Richoux J. P., Grignon G., Bouhnik J., Baussant T., Alhenc-Gelas F. and Corvol P. (1991) Immunocytochemical localization of albumin, transferrin, angiotensinogen and kininogens during the initial stages of rat liver differentiation. Histochemistry 96, 7-12.
25. Gibbons G. H., Pratt R. E. and Dzau V. J. (1992) Vascular smooth muscle cell hypertrophy vs hyperplasia. J. Clin. Invest. 90, 456-461.
26. Gomez R. A., Cassis L., Lynch K. R., Chevalier R. L., Wilfong N., Carey R. M. and Peach M. J. (1988) Fetal expression of the angiotensinogen gene. Endocrinology 123, 2298-2302.
27. Gordon D. B. (1983) The role of renin substrate in hypertension. Hypertension 5, 353-362.
28. Hackenthal E. and Klett C. (1993) Angiotensin II and dexamethasone regulate angiotensinogen mRNA by different mechanisms. J. Steroid Biochem. Mol. Biol. 45, 33-40.
29. Hahn A. W., Resink T. J., Mackie E., Scott-Burden T. and Buhler F. R. (1993) Effects of peptide vasoconstrictors on vessel structure. Am. J. Med. 94, 13S-19S.
30. Hata A., Namikawa C., Sasaki M., Sato K., Nakamura T. and Tamura K. (1994) Angiotensinogen as a risk factor for essential hypertension in Japan. J. Clin. Invest. 93, 1285-1287.
31. Hilgenfeldt U., Kellermann W., Kienapfel G. and Jochum M. (1990) Relationship between angiotensinogen, alpha 1-protease inhibitor elastase complex, antithrombin III and C-reactive protein in septic ARDS. Eur. J. Clin. Pharmacol. 38, 125-131.
32. Hong-Brown L. Q. and Deschepper C. F. (1992) Effects of thyroid hormones on angiotensinogen gene expression in rat liver, brain and cultured cells. Endocrinology 130, 1231-1237.
33. Ihara Y., Taii S. and Mori T. (1987) Expression of renin and angiotensinogen genes in the human placental tissues. Endocrinol. Jap. 34, 887-896.
34. Immonen I. (1982) Reduction of plasma renin substrate after parturition; role of renin. Scand. J. Clin. Lab. Invest. 42, 391-394.
35. Immonen I., Fyrquist F., Pohjavuori M. and Simell O. (1981) Age dependence of human plasma renin substrate. Scand. J. Clin. Lab. Invest. 41, 167-170.
36. Isa M. N., Boyd E., Morrison N., Harrop S., Clauser E. and Connor J. M. (1990) Assignment of the human angiotensinogen gene to chromosome 1q42-q43 by non-isotopic in situ hybridization. Genomics 10, 1110.
37. Ishigami T., Umemura S., Iwamoto T., Tamura K., Hibi K., Yamaguchi S., Nyuui N., Kimura K., Miyazaki N. and Ishii M. S. (1995) Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation 91, 951-954.
38. Itoh H., Mukoyama M., Pratt R. E., Gibbons G. H. and Dzau V. J. (1993) Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J. Clin. Invest. 91, 2268-2274.
39. Janiak P., Pillon A., Prost J. and Vilaine J. (1992) Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 20, 737-745.
40. Jespersen C. M., Arnung K., Hagen C., Hilden T., Nielsen F., Nielsen M. D. and Giese J. (1983) Effects of natural oestrogen therapy on blood pressure and renin-angiotensin system in normotensive and hypertensive menopausal women. J. Hypertens. 1, 361-364.
41. Jeunemaitre X., Soubrier F., Kotelevtsev Y. V., Lifton R. P., Williams C. S., Charru A., Hunt S. C., Hopkins P. N., Williams R. R., Laloue J. and Corvol P. (1992) Molecular basis of human hypertension: role of angiotensinogen. Cell 71, 169-180.
42. Johnson I. R. (1980a) Renin substrate, active and acid-activatable renin concentrations in human plasma and endometrium during the normal menstrual cycle. Br. J. Obstet. Gynaecol. 87, 875-882.
43. Kageyama R., Ohkubo H. and Nakanishi S. (1984) Primary structure of human preangiotensinogen deduced from the cloned cDNA sequence. Biochemistry 23, 3603-3609.
44. Kagami S., Border W. L., Miller D. E. and Noble N. A. (1994) Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor β expression in rat glomerular mesangial cells. J. Clin. Invest. 93, 2431-2437.
45. Kalinyak J. E. and Perlman A. J. (1987) Tissue-specific regulation of angiotensinogen mRNA accumulation by dexamethasone. J. biol. Chem. 262, 460-464.
46. Kim H. S., Krege J. H., Kluckman K. D., Hagaman J. R., Hodgin J. B., Best C. F., Jennette J. C., Coffman T. M., Maeda N. and Smithies O. (1995) Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl Acad. Sci. U.S.A. 92, 2735-2739.
47. Klett C., Ganten D., Hellmann W., Kaling M., Ryffel G., Weimar-Ehl T. and Hackenthal E. (1992) Regulation of hepatic angiotensinogen synthesis and secretion by steroid hormones. Endocrinology 130, 3660-3668.
48. Krattenmacher R., Knauthe R., Parczyk K., Walker A., Hilgenfeldt U. and Fritzemeier K. H. (1994) Estrogen action on hepatic synthesis of angiotensinogen and IGF-1:direct and indirect estrogen effects. J. Steroid Biochem. Mol. Biol. 48, 207-214.
49. Lee R. M., Owens G. K., Scott-Burden T., Head R. J., Mulvany M. J. and Schiffnn E. L. (1995) Pathophysiology of smooth muscle in hypertension. Can. J. Physiol. Pharmacol. 73, 574-584.
50. Lenz T., Sealey J. E., August P., James G. D. and Laragh J. H. (1989) Tissue levels of active and total renin, angiotensinogen, human chorionic gonadotrophin, estradiol, and progesterone in human placentas from different methods of delivery. J. Clin. Endocrinol. Metab. 69, 31-37.
51. Lenz T., Sealey J. E. and Tewksbury D. A. (1993) Regional distribution of the angiotensinogens in human placentae. Placenta 14, 695-699.
52. Menard J., Bouhnik J., Clauser E., Richoux J. P. and Corvol P. (1983) Biochemistry and regulation of angiotensinogen. Clin. Exp. Hvpertens. 5, 1005-1019.
53. Morris B. J. (1989) Human renin protein and gene structures: present and future targets for renin blockade in treatment of hypertension. J. Hypertens. Suppl. 7, S9-14.
54. Nibu Y., Takahashi S., Tanimoto K., Murakami K. and Fukamizu A. (1994a) Identification of cell type-dependent enhancer core element located in the 3′-downstream region of the human angiotensinogen gene. J. biol. Chem. 269, 28598-28605.
55. Nibu Y., Tanimoto K., Takahashi S., Ono H., Murakami K. and Fukamizu A. (1994b) A cell type-dependent enhancer core element is located in exon 5 of the human angiotensinogen gene. Biochem. Biophys. Res. Commun. 205, 1102-1108.
56. Olson A. L., Perlman S. and Robillard J. E. (1990) Developmental regulation of angiotensinogen gene expression in sheep. Pediatr. Res. 28, 183-185.
57. Paul M., Wagner J. and Dzau V. J. (1993) Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. J. Clin. Invest. 91, 2058-2064.
58. Phillips M. I., Wielbo D. and Gyurko R. (1994) Antisense inhibition of hypertension: a new strategy for renin-angiotensin candidate genes. Kidney Int. 46, 1554-1556.
59. Printz M. P., Printz J. M., Lewicki J. A. and Gregory T. (1977a) Resolution of multiple forms of human angiotensinogen; isoelectric focusing heterogeneity profile analysis. Circ. Res. 414, 4 Suppl 2, 37-43.
60. Printz M. P., Printz J. M. and Dworschack R. (1977b) Human angiotensinogen: purification, partial characterization, and a comparison with animal prohormones. J. biol. Chem. 292, 1654-1662.
61. Reid I. A. (1977) Effect of angiotensin II and glucocorticoids on plasma angiotensinogen concentration in the dog. Am. J. Physiol. 232, E234-E236.
62. Ron D., Brasier A. and Habener J. (1990) Transcriptional regulation of hepatic angiotensinogen gene expression by the acute-phase response. Mol. Cell Endocrinol. 74, C97-C104.
63. Rutledge D. R., Browe C. S., Kubilis P. S. and Ross E. A. (1994) Analysis of two variants of the angiotensinogen gene in essential hypertensive African-Americans. Am. J. Hypertens. 7, 651-654.
64. Sadoshima J. and Izumo S. (1993) Molecular characterization of angiotensin II induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Circ. Res. 73, 413-423.
65. Sato Y., Hiwada K. and Kokubu T. (1985) Physicochemical characteristics of human high molecular weight angiotensinogen. Life Sci. 37, 371-377.
66. Sernia C., Zeng T., Shinkel T., Kerr D. and Raizada M. (1994) Interactions of glucocorticoids and cyclic AMP in the tissue-specific regulation of angiotensinogen. Kidney Int. 46, 1574-1576.
67. Siimes A. S., Immonen I., Stenman U. H., Karkkainen J. E., Pekonen F. and Fyhrquist F. Y. (1983) Plasma renin substrate in the prediction of pregnancy outcome in threatened abortion. Br. J. Obstet. Gynaecol. 90, 1186-1192.
68. Skinner S. L., Donn J. R., Mazzetti J., Campbell D. J. and Fidge N. H. (1975) Purification, properties and kinetics of sheep and human renin substrates, Aust. J. Exp. Biol. Med. Sci. 53, 77-88.
69. Stein P. E., Tewksbury D. A. and Carrell R. W. (1989) Ovalbumin and angiotensinogen lack serpin S-R conformational change. Biochem. J. 262, 103-107.
70. Stockigt J. R., Hewett M. J., Topliss D. J., Higgs E. J. and Taft P. (1979) Renin and renin substrate in primary adrenal insufficiency: contrasting effects of glucocorticoid and mineralocorticoid deficiency. Am. J. Med. 66, 915-922.
71. Tanimoto K., Sugiyama F., Goto Y., Ishida S., Takimoto E., Yagami K., Fukamizu A. and Murakami K. (1994) Angiotensinogen deficient mice with hypotension. J. biol. Chem, 269, 31334-31337.
72. Tetlow H. J. and Broughton Pipkin F. (1986) Changing renin substrates in human pregnancy. J. Endocrinol. 109, 257-262.
73. Tewksbury D. A. (1983) Angiotensinogen. Fed. Proc. 42, 2724-2728.
74. Tewksbury D. A. and Dart R. A. (1982) High molecular weight angiotensinogen levels in hypertensive pregnant women. Hypertension 4, 729-734.
75. Tewksbury D. A. and Tryon E. S. (1989) Immunochemical comparison of high molecular weight angiotensinogen from amniotic fluid, plasma of men, and plasma of pregnant women. Am. J. Hypertens, 2, 411-413.
76. Tewksbury D. A., Tryon E. S., Burrill R. E. and Dart R. A. (1986) High molecular weight angiotensinogen: a pregnancy associated protein. Clin. Chim. Acta 158, 7-12.
77. Tryon E. S. and Tewksbury D. A. (1995) Kinetic analysis of the reaction of human renin with human high and low molecular weight angiotensinogen. Hypertens. Pregnancy 14, 327-338.
78. Ueno N., Yoshida K., Hirose S., Yokoyama H., Uerara H. and Murakami K. (1984) Angiotensinogen-producing hepatocellular carcinoma. Hypertension 6, 931-933.
79. Urata H., Kinoshita A., Misono K. S., Bumpus F. M. and Husain A. (1990) Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J. biol. Chem. 265, 22348-22357.
80. Walker W. G., Whelton P. K., Saito H., Russell R. P. and Hermann J. (1979) Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1, 287-291.
81. Ward K., Hata A., Jeunemaitre X., Helin C., Nelson L., Namikawa C., Farrington P. F., Ogasawara M., Suzumori K., Tomoda S., Berrebi S., Sasaki M., Corvol P., Lifton R. P. and Lalouel J. (1993) A molecular variant of angiotensinogen associated with pre-eclampsia. Nat. Genet. 4, 59-61.
82. Weber K. T. and Brilla C. G. (1991) Pathological hypertrophy and cardiac interstitium. Circulation 83, 1849-1865.
83. Weir R. J., Fraser R., Lever A. F., Morton J. J., Brown J. J., Kraszewski A., McIlwaine G. M., Robertson J. I. S. and Tree M. (1973) Plasma renin, renin substrate, angiotensin II and aldosterone in hypertensive disease of pregnancy. Lancet i, 291-294.
84. Wintraub B. U., Klickstein L. B., Dzau V. J. and Watt K. W. (1984) Granulocyte-angiotensin system. Identification of angiotensinogen as the plasma protein substrate of leucocyte cathepsin G. Biochemistry 23, 227-232.
85. Wolf G. and Nelson E. G. (1990) Angiotensin II induces cellular hypertrophy in cultured murine proximal tubule cells. Am. J. Physiol. 259, F768-F777.
86. Wright J. W., Krebs L. T., Stobb J. W. and Harding J. W. (1995) The angiotensin IV system: functional implications. Front. Neuroendocrinol. 16, 23-52.
87. Yang G., Merrill D. C., Thompson M. W., Robillard J. E. and Sigmund C. D. (1994) Functional expression of the human angiotensinogen gene in transgenic mice. J. biol. Chem. 269, 32497-32502.